NAMA
VERV
Nikko Asset Management Americas’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,115,466
| Closed | -$5.43M | – | 193 |
|
|
2024
Q2 | $5.43M | Sell |
1,115,466
-1,476,732
| -57% | -$7.19M | 0.06% | 100 |
|
|
2024
Q1 | $34.3M | Buy |
2,592,198
+194,594
| +8% | +$2.58M | 0.34% | 55 |
|
|
2023
Q4 | $33.3M | Buy |
2,397,604
+250,361
| +12% | +$3.48M | 0.32% | 55 |
|
|
2023
Q3 | $28.4M | Sell |
2,147,243
-38,614
| -2% | -$511K | 0.34% | 54 |
|
|
2023
Q2 | $40.9M | Buy |
2,185,857
+587,863
| +37% | +$11M | 0.43% | 48 |
|
|
2023
Q1 | $22.4M | Buy |
1,597,994
+369,547
| +30% | +$5.17M | 0.26% | 54 |
|
|
2022
Q4 | $23.8M | Buy |
1,228,447
+452,750
| +58% | +$8.76M | 0.34% | 53 |
|
|
2022
Q3 | $24.4M | Buy |
775,697
+660,465
| +573% | +$20.8M | 0.31% | 58 |
|
|
2022
Q2 | $1.49M | Buy |
115,232
+49,123
| +74% | +$633K | 0.02% | 173 |
|
|
2022
Q1 | $1.32M | Sell |
66,109
-4,841
| -7% | -$96.8K | 0.01% | 181 |
|
|
2021
Q4 | $2.27M | Sell |
70,950
-7,471
| -10% | -$239K | 0.01% | 159 |
|
|
2021
Q3 | $3.61M | Buy |
+78,421
| New | +$3.61M | 0.02% | 150 |
|